<i>Staphylococcus Aureus</i> (Record no. 66678)

MARC details
000 -LEADER
fixed length control field 02190naaaa2200337uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/39939
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220220050217.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number intechopen.71376
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789845921
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789845938
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5772/intechopen.71376
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hassan Hemeg
Relationship auth
245 10 - TITLE STATEMENT
Title <i>Staphylococcus Aureus</i>
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. IntechOpen
Date of publication, distribution, etc. 2019
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (144 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. <i>Staphylococcus aureus</i> strains are an important medical infectious agent that causes a wide range of pathogeneses starting from colonization of the skin and mucosal surface to severe pathogenic effects such as septicemia. The mortality and morbidity from this pathogen are challenging issues for the healthcare premises. Methicillin Resistant <i>Staphylococcus aureus</i> strains (MRSA) are causing severe infections due to the genes that are resistant to several antibiotics including methicillin, aminoglycosides, and others. Recently, there have been several reports related to failure of treatment plans caused by MRSA that led to Vancomycin Intermediate <i>Staphylococcus aureus</i> strains (VISA) or, in sporadic cases, resistance to the drug of choice. This book highlights the new areas for the treatment of MRSA using natural products. The implementation of specific products produced by this organism can help the scientist to obtain a new window for treatments such as anticancer chemotherapy, antioxidants, etc.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction All rights reserved
-- http://oapen.org/content/about-rights
546 ## - LANGUAGE NOTE
Language note English
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Life Sciences
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Microbiology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Genetics and Molecular Biology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Biochemistry
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Bacteriology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Farhat Afrin
Relationship auth
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hani Ozbak
Relationship auth
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://www.intechopen.com/books/-i-staphylococcus-aureus-i-">https://www.intechopen.com/books/-i-staphylococcus-aureus-i-</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/39939">https://directory.doabooks.org/handle/20.500.12854/39939</a>
Access status 0
Public note DOAB: description of the publication

No items available.